GS
BMY icon

Girard Securities’s Bristol-Myers Squibb BMY Stock Holding History

Girard Securities’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-4,577
Closed -$267K – 165
2016
Q4 		$267K Sell
4,577
-715
-14% -$39.1K 0.23% 126
2016
Q3 		$285K Sell
5,292
-376
-7% -$24.2K 0.29% 99
2016
Q2 		$417K Buy
5,668
+304
+6% +$21.5K 0.38% 77
2016
Q1 		$345K Buy
5,364
+378
+8% +$23.8K 0.34% 89
2015
Q4 		$343K Buy
+4,986
New +$329K 0.34% 89

Other funds holding BMY

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Girard Securities's BMY Position: Q1 2017 in Review

Girard Securities sold out of Bristol-Myers Squibb (BMY) in Q1 2017, closing a stake of 4,577 shares — an estimated $267K sold.

Girard Securities first reported a position in BMY in Q4 2015 and held it in 5 quarters. The position peaked at $417K in Q2 2016. 1,598 funds tracked by Wall St. Rank hold BMY as of Q1 2017.

  • Girard Securities reported no remaining Bristol-Myers Squibb position as of Q1 2017 after selling out during the quarter.
  • Girard Securities sold 4,577 Bristol-Myers Squibb shares in Q1 2017, an estimated $267K.
  • Girard Securities first reported a position in Bristol-Myers Squibb in Q4 2015 and held it in 5 quarters.
  • Girard Securities's Bristol-Myers Squibb position peaked at $417K in Q2 2016.
  • 1,598 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2017.

Based on Girard Securities's 13F filing for Q1 2017, filed 15 May 2017.